Latest for Arrakis Therapeutics

Endpoints News: Roche makes a platform play, betting $190M in cash on Arrakis’ long-haul plans to drug RNA
Highlight

Endpoints News: Roche makes a platform play, betting $190M in cash on Arrakis’ long-haul plans to drug RNA

Roche is putting Arrakis’ growing team to work on a full slate of targets that touches every corner of their expansive pipeline priorities.
STAT News: Arrakis' lofty goal: Kill cancer with pills that target RNA instead of proteins
Highlight

STAT News: Arrakis' lofty goal: Kill cancer with pills that target RNA instead of proteins

The startup is trying to achieve a feat once thought to be biotech fantasy: Develop oral medicines - pills - that can target RNA, the...
Activity

STAT News: Roche partners with Arrakis Therapeutics to develop drugs that target RNA

Activity

FierceBiotech: Biotech Arrakis, Roche team up on RNA-targeting drugs in $190M deal

Activity

STAT: Biotech dreams of drugging the “undruggable”

Activity

Colleen Cuffaro: Arrakis Therapeutics: Redefining the druggable target